500
0
0

November is Lung Cancer Awareness Month. Explore both sides of lung cancer diagnosis →

Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
🔍
Folder: Who We Are
Back
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Folder: Reports
Back
Annual Reports
SCLC Report
Policy and resources
English
Back
Our Members
No results found
Access to treatment, Policy and EU affairs Web Team 08/10/2026 Access to treatment, Policy and EU affairs Web Team 08/10/2026

New European report calls for faster access to cancer research and care

Read More
Access to treatment, Policy and EU affairs Web Team 30/09/2026 Access to treatment, Policy and EU affairs Web Team 30/09/2026

Advocating for more inclusive clinical trials across Europe

Read More
Policy and EU affairs, Access to treatment Web Team 17/09/2026 Policy and EU affairs, Access to treatment Web Team 17/09/2026

New lung health equity framework covers lung cancer and COPD

Read More
Biomarkers and diagnosis, Access to treatment Web Team 05/08/2026 Biomarkers and diagnosis, Access to treatment Web Team 05/08/2026

Biomarker testing is moving faster than ever. Is Europe keeping up?

Read More
Access to treatment, Treatment and research Web Team 25/07/2026 Access to treatment, Treatment and research Web Team 25/07/2026

A new ROS1 lung cancer drug has reached patients in the US. What happens next in Europe?

Read More
Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026

When care happens is as important as what happens: the case for timed targets in lung cancer

Read More
Access to treatment Web Team 01/07/2026 Access to treatment Web Team 01/07/2026

Access to Treatment Atlas: compare lung cancer treatment access across Europe

Read More
Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026

What the EU Critical Medicines Act means for lung cancer

Read More
Access to treatment Web Team 01/07/2026 Access to treatment Web Team 01/07/2026

England catches up on cemiplimab for advanced lung cancer

Read More
Access to treatment, Policy and EU affairs Web Team 30/06/2026 Access to treatment, Policy and EU affairs Web Team 30/06/2026

EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer

Read More
Access to treatment, Policy and EU affairs Web Team 25/06/2026 Access to treatment, Policy and EU affairs Web Team 25/06/2026

Could innovative medicines save more than they cost? What this new report means for lung cancer

Read More
Policy and EU affairs, Access to treatment Web Team 10/06/2026 Policy and EU affairs, Access to treatment Web Team 10/06/2026

PFAS restrictions and medicines: what is the EU proposing, and how it might affect lung cancer treatment

The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.

Read More
Access to treatment Web Team 23/05/2026 Access to treatment Web Team 23/05/2026

Europe’s Medicine Access Crisis: What the Latest Data Means for Lung Cancer

Read More
Access to treatment, Policy and EU affairs Web Team 16/05/2026 Access to treatment, Policy and EU affairs Web Team 16/05/2026

Why people with lung cancer in Europe are being left behind on clinical trials

Read More
Access to treatment, Treatment and research Web Team 04/05/2026 Access to treatment, Treatment and research Web Team 04/05/2026

What is subcutaneous pembrolizumab and what does the NHS rollout mean for people living with lung cancer in Europe?

Read More
Lung Cancer Europe and members, Access to treatment Web Team 30/04/2026 Lung Cancer Europe and members, Access to treatment Web Team 30/04/2026

How Athena. Women Against Cancer Keep Fighting for Lung Cancer Access in Ukraine

Read More
Policy and EU affairs, Access to treatment Web Team 30/04/2026 Policy and EU affairs, Access to treatment Web Team 30/04/2026

How the EU HTA Regulation is Changing Lung Cancer Treatment Assessment in Europe

Read More
Biomarkers and diagnosis, Access to treatment Web Team 18/04/2026 Biomarkers and diagnosis, Access to treatment Web Team 18/04/2026

Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece

Read More
Treatment and research, Access to treatment Web Team 31/03/2026 Treatment and research, Access to treatment Web Team 31/03/2026

EMA recommends tarlatamab for relapsed extensive-stage SCLC

Read More
Access to treatment Web Team 10/03/2026 Access to treatment Web Team 10/03/2026

Cyclophosphamide supply shortage reported in Europe

Read More
Older Posts

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on the 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY
COMPLIANCE

© Lung Cancer Europe 2026 | Designed by Laura Jones